Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nal-IRI plus 5-FU/Leucovorin in Advanced Biliary Tract Cancer
NCT03043547Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Oct 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan liposome injection in cholangiocarcinoma (CCA), gallbladder carcinoma, sponsored by AIO-Studien. Started Oct 2017; status: completed.
02
Drugs
irinotecan liposome injection
03
Conditions
cholangiocarcinoma (CCA)gallbladder carcinoma
Beyond the preview
Go deeper on NCT03043547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03043547.